Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care
暂无分享,去创建一个
M. Ruiz | F. Dulley | F. Coracin | R. Saboya | L. P. Ruiz | P. Musqueira | Alessandra Barban | Andrea Barban | P. T. Musqueira
[1] A. Levin,et al. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[2] L. C. Ribeiro,et al. Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution. , 2012, Sao Paulo medical journal = Revista paulista de medicina.
[3] A. Pickard,et al. Outcome, toxicity profile and cost analysis of autologous stem cell mobilization , 2011, Bone Marrow Transplantation.
[4] M. Kersten,et al. Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment. , 2011, Journal of clinical nursing.
[5] S. Fernandez,et al. Delayed administration of filgrastim (G‐CSF) following autologous peripheral blood stem cell transplantation (APBSCT) in pediatric patients does not change time to neutrophil engraftment and reduces use of G‐CSF , 2010, Pediatric blood & cancer.
[6] D. Speckhart,et al. Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM , 2010, Bone Marrow Transplantation.
[7] P. Kiel,et al. Peripheral Blood Stem Cell Mobilization Tactics , 2010, The Annals of pharmacotherapy.
[8] K. Conceição,et al. NURSE-PATIENT RELATIONSHIP: CARE AS THERAPY RELACIONAMIENTO ENFERMERA/PACIENTE: PERSPECTIVA TERAPÉUTICA DEL CUIDADO , 2010 .
[9] Josicélia Dumêt Fernandes,et al. Relacionamento enfermeira/paciente: perspectiva terapêutica do cuidado , 2010 .
[10] K. Acar,et al. Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation , 2010, Journal of clinical apheresis.
[11] H. Einsele,et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. , 2009, Bone marrow transplantation.
[12] Hermann Einsele,et al. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.
[13] L. Castagna,et al. Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease , 2009, Leukemia & lymphoma.
[14] D. Chamone,et al. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[15] Alfredo Mendrone Júnior. Coleta de células progenitoras hematopoéticas de sangue periférico após administração de ciclofosfamida e fator estimulador de colônias de granulócitos (G-CSF): uma análise de 307 pacientes , 2008 .
[16] J. Styczyński,et al. Infectious Complication in 314 Patients after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation: Risk Factors Analysis and Outcome , 2007, Infection.
[17] O. Arslan,et al. Mobilization of peripheral blood stem cells. , 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[18] Joseph D Tariman,et al. The role of high-dose chemotherapy supported by hematopoietic stem cell transplantation in patients with multiple myeloma: implications for nursing. , 2007, Clinical journal of oncology nursing.
[19] E. Montserrat,et al. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] W. Kern. Outpatient management in patients with neutropenia after intensive chemotherapy--is it safe? , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] J. E. Nicolau. O transplante de medula óssea alogênico de curto período de internação , 2004 .
[22] E. Schiavone,et al. Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma. , 2004, The hematology journal : the official journal of the European Haematology Association.
[23] E. Hacker. Quantitative measurement of quality of life in adult patients undergoing bone marrow transplant or peripheral blood stem cell transplant: a decade in review. , 2003, Oncology nursing forum.
[24] A. Mank,et al. Is there still an indication for nursing patients with prolonged neutropenia in protective isolation?. An evidence-based nursing and medical study of 4 years experience for nursing patients with neutropenia without isolation. , 2003, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[25] E. Oliva,et al. Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma. , 2002, Haematologica.
[26] K. Cornetta,et al. Longitudinal study of adaptation to the stress of bone marrow transplantation. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Cessie,et al. Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. , 2000, Journal of psychosomatic research.
[28] D. Dorsky,et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation , 2000, Bone Marrow Transplantation.
[29] K. Vedhara,et al. A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation , 1999, Bone Marrow Transplantation.
[30] C. Buckner. Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: a historical perspective. , 1999, Journal of hematotherapy.
[31] P. Jacobsen,et al. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. , 1999, Journal of pain and symptom management.
[32] S. McCann,et al. Psychosocial adaptation of patients and families following bone marrow transplantation: a prospective, longitudinal study , 1998, Bone Marrow Transplantation.
[33] J. Perfect,et al. Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.